Susquehanna International Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-53,600
| Closed | -$662K | – | 13775 |
|
|
2024
Q4 | $662K | Buy |
+53,600
| New | +$614K | ﹤0.01% | 7976 |
|
|
2023
Q3 | – | Sell |
-15,700
| Closed | -$219K | – | 13198 |
|
|
2023
Q2 | $219K | Sell |
15,700
-13,400
| -46% | -$228K | ﹤0.01% | 10099 |
|
|
2023
Q1 | $546K | Buy |
29,100
+6,600
| +29% | +$108K | ﹤0.01% | 8365 |
|
|
2022
Q4 | $310K | Buy |
22,500
+10,300
| +84% | +$158K | ﹤0.01% | 9024 |
|
|
2022
Q3 | $233K | Buy |
+12,200
| New | +$222K | ﹤0.01% | 10449 |
|
|
2022
Q1 | – | Sell |
-34,000
| Closed | -$992K | – | 14170 |
|
|
2021
Q4 | $992K | Buy |
34,000
+6,800
| +25% | +$195K | ﹤0.01% | 7321 |
|
|
2021
Q3 | $587K | Sell |
27,200
-43,900
| -62% | -$1.06M | ﹤0.01% | 8958 |
|
|
2021
Q2 | $1.82M | Buy |
71,100
+14,500
| +26% | +$310K | ﹤0.01% | 6127 |
|
|
2021
Q1 | $1.03M | Buy |
56,600
+25,800
| +84% | +$429K | ﹤0.01% | 7660 |
|
|
2020
Q4 | $355K | Sell |
30,800
-8,300
| -21% | -$75.9K | ﹤0.01% | 8943 |
|
|
2020
Q3 | $298K | Sell |
39,100
-23,100
| -37% | -$175K | ﹤0.01% | 8721 |
|
|
2020
Q2 | $408K | Buy |
62,200
+37,800
| +155% | +$211K | ﹤0.01% | 7787 |
|
|
2020
Q1 | $125K | Sell |
24,400
-9,100
| -27% | -$55.1K | ﹤0.01% | 9161 |
|
|
2019
Q4 | $257K | Sell |
33,500
-4,500
| -12% | -$26.3K | ﹤0.01% | 8318 |
|
|
2019
Q3 | $201K | Buy |
38,000
+13,900
| +58% | +$86.3K | ﹤0.01% | 9087 |
|
|
2019
Q2 | $135K | Buy |
24,100
+9,200
| +62% | +$37.9K | ﹤0.01% | 9450 |
|
|
2019
Q1 | $63K | Sell |
14,900
-13,700
| -48% | -$55.9K | ﹤0.01% | 8416 |
|
|
2018
Q4 | $117K | Sell |
28,600
-30,100
| -51% | -$157K | ﹤0.01% | 8142 |
|
|
2018
Q3 | $403K | Buy |
58,700
+26,600
| +83% | +$158K | ﹤0.01% | 6918 |
|
|
2018
Q2 | $126K | Sell |
32,100
-4,100
| -11% | -$14.2K | ﹤0.01% | 8950 |
|
|
2018
Q1 | $106K | Sell |
36,200
-6,200
| -15% | -$19.2K | ﹤0.01% | 8677 |
|
|
2017
Q4 | $165K | Buy |
42,400
+27,700
| +188% | +$119K | ﹤0.01% | 8427 |
|
|
2017
Q3 | $46K | Buy |
14,700
+13,029
| +780% | +$48.9K | ﹤0.01% | 8558 |
|
|
2017
Q2 | $7K | Sell |
1,671
-1,572
| -48% | -$6.43K | ﹤0.01% | 9085 |
|
|
2017
Q1 | $15K | Buy |
+3,243
| New | +$10.9K | ﹤0.01% | 8759 |
|
|
2016
Q4 | – | Sell |
-1,614
| Closed | -$5K | – | 10282 |
|
|
2016
Q3 | $5K | Hold |
1,614
| – | – | ﹤0.01% | 8309 |
|
|
2016
Q2 | $4K | Sell |
1,614
-10,086
| -86% | -$28.1K | ﹤0.01% | 8445 |
|
|
2016
Q1 | $34K | Sell |
11,700
-7,257
| -38% | -$38.8K | ﹤0.01% | 8740 |
|
|
2015
Q4 | $155K | Buy |
18,957
+386
| +2% | +$3.12K | ﹤0.01% | 8634 |
|
|
2015
Q3 | $133K | Sell |
18,571
-15
| -0.1% | -$125 | ﹤0.01% | 8994 |
|
|
2015
Q2 | $170K | Buy |
18,586
+9,129
| +97% | +$87.8K | ﹤0.01% | 9418 |
|
|
2015
Q1 | $89K | Buy |
9,457
+7,771
| +461% | +$74.8K | ﹤0.01% | 9002 |
|
|
2014
Q4 | $16K | Sell |
1,686
-22,985
| -93% | -$231K | ﹤0.01% | 9495 |
|
|
2014
Q3 | $235K | Buy |
24,671
+12,000
| +95% | +$134K | ﹤0.01% | 8402 |
|
|
2014
Q2 | $167K | Buy |
12,671
+6,185
| +95% | +$78K | ﹤0.01% | 9191 |
|
|
2014
Q1 | $86K | Buy |
6,486
+4,886
| +305% | +$64.3K | ﹤0.01% | 8605 |
|
|
2013
Q4 | $16K | Sell |
1,600
-1,471
| -48% | -$13.8K | ﹤0.01% | 8907 |
|
|
2013
Q3 | $30K | Sell |
3,071
-5,915
| -66% | -$58.8K | ﹤0.01% | 8291 |
|
|
2013
Q2 | $81K | Buy |
+8,986
| New | +$94.2K | ﹤0.01% | 7862 |
|
Other funds holding CDMO
Susquehanna International Group's CDMO Position: Q1 2025 in Review
Susquehanna International Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 48,131 shares — an estimated $594K sold.
Susquehanna International Group first reported a position in CDMO in Q2 2013 and held it in 40 quarters. The position peaked at $6.36M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Susquehanna International Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Susquehanna International Group sold 48,131 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $594K.
- Susquehanna International Group first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 40 quarters.
- Susquehanna International Group's Avid Bioservices, Inc. Common Stock position peaked at $6.36M in Q1 2023.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.